A general method for functionalising both the C- and N-terminals of Tyr3-octreotate

This publication has 12 references indexed in Scilit:

• Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide
  European Journal of Nuclear Medicine and Molecular Imaging, 2001
• 99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives
  European Journal of Nuclear Medicine and Molecular Imaging, 2000
• Radiometal-Labelled Macrocyclic Chelator-Derivatised Somatostatin Analogue with Superb Tumour-Targeting Properties and Potential for Receptor-Mediated Internal Radiotherapy
  Chemistry – A European Journal, 1999
• The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors
  Endocrine Reviews, 1991
• The effect of a somatostatin analogue on the release of hormones from human midgut carcinoid tumour cells
  British Journal of Cancer, 1991
• Improved method for the synthesis of o-glycosylated fmoc amino acids to be used in solid-phase glycopeptide synthesis (Fmoc = fluoren-9-ylmethoxycarbonyl)
  Journal of the Chemical Society, Chemical Communications, 1990
• Prolonged secretion of prolactin in response to thyrotrophin-releasing hormone after hypothalamo-pituitary disconnection in the ewe
  Journal of Endocrinology, 1986
• SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
  Life Sciences, 1982
• Facile synthesis of amino acid and peptide esters under mild conditions via cesium salts
  The Journal of Organic Chemistry, 1977
• Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone
  Science, 1973